{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:46:16Z","timestamp":1789685176489,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T00:00:00Z","timestamp":1356048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s12098-012-0940-4","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T10:08:20Z","timestamp":1355998100000},"page":"570-575","source":"Crossref","is-referenced-by-count":7,"title":["Acquired Thrombotic Thrombocytopenic Purpura in Children: A Single Institution Experience"],"prefix":"10.1007","volume":"80","author":[{"given":"Somasundaram","family":"Jayabose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore S.","family":"Nowicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oya","family":"Levendoglu-Tugal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet F.","family":"Ozkaynak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,21]]},"reference":[{"key":"940_CR1","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1056\/NEJMcp053024","volume":"354","author":"JN George","year":"2006","unstructured":"George JN. Thrombotic thrombocytopenia purpura. N Engl J Med. 2006;354:1927\u201335.","journal-title":"N Engl J Med"},{"key":"940_CR2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.ATV.0000058401.34021.D4","volume":"23","author":"HM Tsai","year":"2003","unstructured":"Tsai HM. Platelet activation and the formation of the platelet plug: deficiency of ADAMTS13 causes thrombotic thrombocytopenia purpura. Aterioscler Thromb Vasc Biol. 2003;23:388\u201396.","journal-title":"Aterioscler Thromb Vasc Biol"},{"key":"940_CR3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2008-02-078170","volume":"112","author":"JE Sadler","year":"2008","unstructured":"Sadler JE. Von Willebrand factor, ADAMTS13, and thrombocytopenic purpura. Blood. 2008;112:11\u20138.","journal-title":"Blood"},{"key":"940_CR4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","volume":"413","author":"GG Levy","year":"2001","unstructured":"Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS13 gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413:488\u201394.","journal-title":"Nature"},{"key":"940_CR5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ajh.2830500203","volume":"50","author":"TJ Torok","year":"1995","unstructured":"Torok TJ, Holman RC, Chorba TL. Increasing mortality from TTP in the United States-Analysis of national mortality data 1968\u20131991. Am J Hematol. 1995;50:84\u201390.","journal-title":"Am J Hematol"},{"key":"940_CR6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00043426-200304000-00016","volume":"25","author":"TM Horton","year":"2003","unstructured":"Horton TM, Stone JD, Yee D, et al. Case series of thrombotic thrombocytopenic purpura in children and adolescents. J Pediatr Hematol Oncol. 2003;25:336\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"key":"940_CR7","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/j.lpm.2011.10.027","volume":"41","author":"H Yagi","year":"2012","unstructured":"Yagi H, Matsumuto M, Fujimara Y. Paradigm shift of childhood TTP with severe ADAMTS13 deficiency. Presse Med. 2012;41:e137\u201355.","journal-title":"Presse Med"},{"key":"940_CR8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/pbc.22094","volume":"53","author":"M Bouw","year":"2009","unstructured":"Bouw M, Dors N, van Ommen H, Ramakers-Van Woerden N. Thrombotic thrombocytopenic purpura in childhood. Pediatr Blood Cancer. 2009;53:537\u201342.","journal-title":"Pediatr Blood Cancer"},{"key":"940_CR9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00467-008-0863-5","volume":"24","author":"C Loirat","year":"2009","unstructured":"Loirat C, Girma J, Desconclois C, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children. Pediatr Nephrol. 2009;24:19\u201329.","journal-title":"Pediatr Nephrol"},{"key":"940_CR10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00043426-200305000-00015","volume":"25","author":"S Jayabose","year":"2003","unstructured":"Jayabose S, Levendoglu-Tugal O, Ozkaynak MF, Chao CP, Cuccovia B, Sandoval C. Use of vincristine and cyclosporine in childhood thrombotic thrombocytopenic purpura. J Pediatr Hematol Oncol. 2003;25:421\u20135.","journal-title":"J Pediatr Hematol Oncol"},{"key":"940_CR11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/08880011003739414","volume":"28","author":"S Jayabose","year":"2010","unstructured":"Jayabose S, Dunbar J, Nowicki TS, Tugal O, Ozkaynak MF, Sandoval C. Rituximab therapy to prevent relapse in chronic relapsing thrombotic thrombocytopenic purpura (TTP) in a child. Pediatr Hematol Oncol. 2010;28:167\u201372.","journal-title":"Pediatr Hematol Oncol"},{"key":"940_CR12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/MPH.0b013e3181ec0ede","volume":"33","author":"R Mathew","year":"2011","unstructured":"Mathew R, Huang J, Katta US, Krishan U, Sandoval C, Gewitz M. Immunosuppressant-induced endothelial damage and pulmonary arterial hypertension. J Pediatr Hematol Oncol. 2011;33:55\u20138.","journal-title":"J Pediatr Hematol Oncol"},{"key":"940_CR13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","volume":"325","author":"GA Rock","year":"1991","unstructured":"Rock GA, Shamak KH, Buskand NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of TTP. N Engl J Med. 1991;325:393\u20137.","journal-title":"N Engl J Med"},{"key":"940_CR14","doi-asserted-by":"crossref","unstructured":"Mannucci PM, Peyvandi F. TTP and ADAMTS13: when is testing appropriate? Hematol Am Soc Hematol Educ Program. 2007;121\u20136.","DOI":"10.1182\/asheducation-2007.1.121"},{"key":"940_CR15","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","volume":"115","author":"JA Hovinga","year":"2010","unstructured":"Hovinga JA, Vesely SK, Terrell DR, L\u00e4mmle B, George JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2010;115:1500\u201311.","journal-title":"Blood"},{"key":"940_CR16","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1182\/blood-2006-02-006064","volume":"109","author":"S Ferrari","year":"2007","unstructured":"Ferrari S, Scheiflinger F, Rieger M, Mudde G, Wolf M, Coppo P, et al. Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity. Blood. 2007;109:2815\u201322.","journal-title":"Blood"},{"key":"940_CR17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1160\/TH07-12-0753","volume":"101","author":"E Bresin","year":"2009","unstructured":"Bresin E, Gastoldi S, Daina E, Belotti D, Pogliani E, Perseghin P, et al. Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies. Thromb Haemost. 2009;101:233\u20138.","journal-title":"Thromb Haemost"},{"key":"940_CR18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2003-01-0193","volume":"102","author":"SK Vesely","year":"2003","unstructured":"Vesely SK, George JN, Lammle B, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003;102:60\u20138.","journal-title":"Blood"},{"key":"940_CR19","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1537-2995.2009.02101.x","volume":"49","author":"AS Kennedy","year":"2009","unstructured":"Kennedy AS, Lewis QF, Scott JG, et al. Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009;49:1092\u2013101.","journal-title":"Transfusion"},{"key":"940_CR20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.0b013e3181aaea1b","volume":"73","author":"TM Burrus","year":"2009","unstructured":"Burrus TM, Wijdicks EF, Rabinstein AA. Brain lesions are most often reversible in acute thrombotic thrombocytopenic purpura. Neurology. 2009;73:66\u201370.","journal-title":"Neurology"},{"key":"940_CR21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/0961203308094360","volume":"18","author":"SK Kwok","year":"2009","unstructured":"Kwok SK, Ju JH, Cho CS, Kim HY, Park SH. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study. Lupus. 2009;18:16\u201321.","journal-title":"Lupus"},{"key":"940_CR22","first-page":"363","volume":"9","author":"WK Chak","year":"2003","unstructured":"Chak WK, Lam DS, Lo WH, Hui CM, Wong SN. Thrombotic thrombocytopenic purpura as a rare complication in childhood systemic lupus erythematosus: case report and literature review. Hong Kong Med J. 2003;9:363\u20138.","journal-title":"Hong Kong Med J"},{"key":"940_CR23","first-page":"246","volume":"42","author":"HI Brunner","year":"1999","unstructured":"Brunner HI, Freedman M, Silverman ED. Close relationship between SLE and TTP in childhood. Arthritis Rheum. 1999;42:246\u20135.","journal-title":"Arthritis Rheum"},{"key":"940_CR24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s002770000187","volume":"79","author":"J Chemnitz","year":"2000","unstructured":"Chemnitz J, Fuchs M, Blau W, et al. Fatal thrombotic thrombocytopenic purpura as a rare complication following allogeneic stem cell transplantation. Ann Hematol. 2000;79:527\u20139.","journal-title":"Ann Hematol"},{"key":"940_CR25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jca.10008","volume":"16","author":"J Teruya","year":"2001","unstructured":"Teruya J, Styler M, Verde S, et al. Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation. J Clin Apheresis. 2001;16:169\u201374.","journal-title":"J Clin Apheresis"},{"key":"940_CR26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00062752-200109000-00004","volume":"8","author":"PJ Medina","year":"2001","unstructured":"Medina PJ, Sipols JM, George JN. Drug-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Op Hematol. 2001;8:286\u201393.","journal-title":"Curr Op Hematol"},{"key":"940_CR27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4065\/78.4.421","volume":"78","author":"MA Elliott","year":"2003","unstructured":"Elliott MA, Nichols Jr WL, Plumhoff EA, et al. Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review. Mayo Clin Proc. 2003;78:421\u201330.","journal-title":"Mayo Clin Proc"},{"key":"940_CR28","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1046\/j.1365-2141.2002.03721.x","volume":"118","author":"T Ruutu","year":"2002","unstructured":"Ruutu T, Hermans J, Niederwieser D, et al. Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol. 2002;118:1112\u20139.","journal-title":"Br J Haematol"},{"key":"940_CR29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00005792-200301000-00003","volume":"82","author":"P Coppo","year":"2003","unstructured":"Coppo P, Bussel A, Charrier S, et al. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome. Med (Baltimore). 2003;82:27\u201338.","journal-title":"Med (Baltimore)"},{"key":"940_CR30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0609.2009.01292.x","volume":"83","author":"MA Elliott","year":"2009","unstructured":"Elliott MA, Heit JA, Pruthi RK, Gastineau DA, Winters JL, Hook CC. Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature. Eur J Haematol. 2009;83:365\u201372.","journal-title":"Eur J Haematol"},{"key":"940_CR31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12098-010-0224-9","volume":"78","author":"S Tripathi","year":"2011","unstructured":"Tripathi S, Deshpande A, Khadse S, Kulkarni R. A case of thrombotic thrombocytopenic purpura with cerebral infarct secondary to platelet transfusion. Ind Ped. 2011;78:109\u201311.","journal-title":"Ind Ped"},{"key":"940_CR32","doi-asserted-by":"crossref","unstructured":"Narayanan P, Jayaraman A, Rustaqi RS, Mahadevan S, Parameswaran S. Rituximab in a child with autoimmune thrombotic thrombocytopenic purura refractory to plasma exchange. Int J Hematol. 2012;3. Epub ahead of print.","DOI":"10.1007\/s12185-012-1089-7"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-012-0940-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-012-0940-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-012-0940-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T04:50:46Z","timestamp":1595134246000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-012-0940-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,21]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["940"],"URL":"https:\/\/doi.org\/10.1007\/s12098-012-0940-4","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,21]]}}}